| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1464-5491.2003.00990.X |
| P698 | PubMed publication ID | 12925051 |
| P2093 | author name string | Pickup JC | |
| Mattock MB | |||
| P2860 | cites work | C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 |
| C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | Q29619398 | ||
| Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study | Q31829404 | ||
| Relationship between blood glucose level and mortality in type 2 diabetes mellitus: a systematic review | Q33608611 | ||
| Hyperglycemia and cardiovascular disease in type 2 diabetes | Q33637016 | ||
| Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23) | Q33764951 | ||
| Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses | Q33910496 | ||
| Serum sialic acid concentration and cardiovascular mortality | Q35178190 | ||
| Diabetes mellitus and macrovascular complications. An epidemiological perspective | Q35373989 | ||
| Haematological stress syndrome in atherosclerosis | Q39338214 | ||
| Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus | Q39768901 | ||
| Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease ? chicken, egg or neither? | Q40174964 | ||
| High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes | Q40663999 | ||
| The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study | Q43748961 | ||
| C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study | Q43972578 | ||
| Is type II diabetes mellitus a disease of the innate immune system? | Q48364597 | ||
| NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. | Q50920620 | ||
| Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). | Q51555318 | ||
| Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes. | Q51558660 | ||
| Serum Sialic Acid Concentration and Coronary Heart Disease in NIDDM | Q51586937 | ||
| Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study | Q68057951 | ||
| Prospective study of microalbuminuria as predictor of mortality in NIDDM | Q68127291 | ||
| Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients | Q68325939 | ||
| Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study | Q77769452 | ||
| P433 | issue | 9 | |
| P921 | main subject | circulatory system | Q11068 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 723-726 | |
| P577 | publication date | 2003-09-01 | |
| P1433 | published in | Diabetic Medicine | Q15758639 |
| P1476 | title | Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus | |
| P478 | volume | 20 |
| Q36914125 | Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus |
| Q35055027 | Antihypertriglyceridemia and anti-inflammatory activities of monascus-fermented dioscorea in streptozotocin-induced diabetic rats. |
| Q64096487 | Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study |
| Q91850790 | Diabetes, depressive symptoms, and mortality risk in old age: The role of inflammation |
| Q33846083 | Diet-induced adiposity alters the serum profile of inflammation in C57BL/6N mice as measured by antibody array |
| Q58230169 | Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus |
| Q44312736 | Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes |
| Q36082148 | Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications |
| Q38342034 | Leptin administration downregulates the increased expression levels of genes related to oxidative stress and inflammation in the skeletal muscle of ob/ob mice |
| Q37157478 | Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS) |
| Q24801508 | Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review |
| Q36264672 | Sialic acid in cardiovascular diseases |
| Q47807059 | The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study |
| Q36629490 | Vitamin D Receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach |
Search more.